The calcium supplement industry in Japan is expected to develop at a CAGR of 10.0% through 2033. The demand for calcium supplement in Japan is expected to grow significantly, reaching US$ 153.3 million in 2023.
The contemporary generation's holistic attitude to health and well-being has spurred solutions that address issues ranging from dietary inadequacies to lifestyle disorders. Therefore, the calcium supplement industry in Japan is anticipated to be worth US$ 395.8 million by 2033.
Key Highlights:
Attributes | Key Statistics |
---|---|
Expected Base Year Value (2023) | US$ 153.3 million |
Anticipated Forecast Value (2033) | US$ 395.8 million |
Estimated Growth (2023 to 2033) | 10.0% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Attributes | Details |
---|---|
Form | Soft Gel Pills |
Industry Share in 2023 | 49.8% |
Attributes | Details |
---|---|
End Use | Men |
Industry Share in 2023 | 39.5% |
The competitive landscape of the calcium supplement industry in Japan is quickly expanding, owing to an aging population, increased health consciousness, and a growing desire for self-care. Leading companies in the Japan calcium supplement industry include Eisai, Morinaga Milk Industry, UNIMAT RIKEN, ORIHIRO, Asahi Group, Otsuka, DHC, Bean Stalk Snow, Dainippon Pharmaceutical, and Kobayashi Pharmaceutical.
These firms offer a wide range of calcium supplements, catering to various customer sectors and demands. The industry in Japan is predicted to experience further growth in the future years. New product innovations, such as calcium supplements with additional nutrients or functional components, are also anticipated to impact the industry.
Recent Developments in the Calcium Supplement Industry in Japan
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attribute | Details |
---|---|
Estimated Valuation (2023) | US$ 153.3 million |
Projected Valuation (2033) | US$ 395.8 million |
Anticipated CAGR (2023 to 2033) | 10.0% CAGR |
Historical Analysis of Calcium Supplement in Japan | 2018 to 2022 |
Demand Forecast for Calcium Supplement in Japan | 2023 to 2033 |
Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
Report Coverage | Industry Size, Industry Trends, Key Insights for Calcium supplement Adoption in Japan, Insights on Global Players and Leading Industry Strategy in Japan, Ecosystem Analysis of Local and Regional Industry. |
Key Companies Profiled | Eisai Company, Ltd.; Morinaga Milk Industry; Dainippon Pharmaceutical; Kobayashi Pharmaceutical; Rohto Pharmaceutical Co.; Daiwa Pharmaceutical Co.; Kyowa Hakko Bio Co., Ltd.; Suntory Beverage & Food Limited; UNIMAT RIKEN; ORIHIRO; Asahi Group; Otsuka; DHC; Bean Stalk Snow |
The anticipated CAGR for the Japan calcium supplement industry through 2033 is 10.0%.
Demand for calcium supplement in Japan is likely to surpass US$ 395.8 million by 2033.
In 2023, the industry size of the calcium supplement in Japan is anticipated to be US$ 153.3 million.
Soft gel pills are the preferred form of calcium supplement in Japan, with an industry share of 49.8%.
In Japan, male population dominates the calcium supplement industry, with a share of 39.5%.
1. Executive Summary 1.1. Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Type, 2023 to 2033 5.3.1. Gummy 5.3.2. Pill 5.3.3. Capsule 5.3.4. Liquid 5.3.5. Others 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Product 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Product, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Product, 2023 to 2033 6.3.1. Calcium Carbonate 6.3.2. Calcium Gluconate 6.3.3. Calcium Citrate 6.3.4. Calcium Lactate 6.3.5. Calcium Phosphate 6.3.6. Calcium Orotate 6.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Applications 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Applications, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Applications, 2023 to 2033 7.3.1. Adult 7.3.2. Children 7.4. Y-o-Y Growth Trend Analysis By Applications, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Applications, 2023 to 2033 8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2023 to 2033 8.3.1. Kanto 8.3.2. Chubu 8.3.3. Kinki 8.3.4. Kyushu & Okinawa 8.3.5. Tohoku 8.3.6. Rest of 8.4. Market Attractiveness Analysis By Region 9. Kanto Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Type 9.2.2. By Product 9.2.3. By Applications 9.3. Market Attractiveness Analysis 9.3.1. By Type 9.3.2. By Product 9.3.3. By Applications 9.4. Key Takeaways 10. Chubu Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Type 10.2.2. By Product 10.2.3. By Applications 10.3. Market Attractiveness Analysis 10.3.1. By Type 10.3.2. By Product 10.3.3. By Applications 10.4. Key Takeaways 11. Kinki Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Type 11.2.2. By Product 11.2.3. By Applications 11.3. Market Attractiveness Analysis 11.3.1. By Type 11.3.2. By Product 11.3.3. By Applications 11.4. Key Takeaways 12. Kyushu & Okinawa Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Type 12.2.2. By Product 12.2.3. By Applications 12.3. Market Attractiveness Analysis 12.3.1. By Type 12.3.2. By Product 12.3.3. By Applications 12.4. Key Takeaways 13. Tohoku Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Type 13.2.2. By Product 13.2.3. By Applications 13.3. Market Attractiveness Analysis 13.3.1. By Type 13.3.2. By Product 13.3.3. By Applications 13.4. Key Takeaways 14. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Type 14.2.2. By Product 14.2.3. By Applications 14.3. Market Attractiveness Analysis 14.3.1. By Type 14.3.2. By Product 14.3.3. By Applications 14.4. Key Takeaways 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Type 15.3.3. By Product 15.3.4. By Applications 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Otsuka Pharmaceutical Co., Ltd. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Morishita Jintan Co., Ltd 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Umeken 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Pfizer (Caltrate) 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. AandZ Pharmaceutical 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Amway(Nutrilite) 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Shanxi Zhendong Pharmaceutical Co., Ltd. 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Nature Made 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. By-health Co., Ltd. 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Harbin Pharmaceutical Group 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports